Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Heating melphalan to several degrees above body temperature and infusing it to the
affected area directly around the tumor may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of hepatic arterial infusion with melphalan
in treating patients who have unresectable liver cancer.